Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.

被引：0
|
作者：
Wong, JB [1 ]
机构：
[1] Tufts New England Med Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1062
引用
收藏
页码：425A / 425A
页数：1
相关论文
共 50 条
  • [21] Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MH
    Albrecht, J
    GASTROENTEROLOGY, 2002, 122 (05) : 1303 - 1313
  • [22] Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    MEDICAL SCIENCE MONITOR, 2010, 16 (12): : CR616 - CR621
  • [23] VIROLOGICAL RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALFA-2B AND RIBAVIRIN CHRONIC HEPATITIS C IN CHILDREN
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    Jendryczka, Ewa
    HEPATOLOGY, 2008, 48 (04) : 855A - 856A
  • [24] Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden
    Bernfort, Lars
    Sennfalt, Karin
    Reichard, Olle
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 497 - 505
  • [25] Safety, efficacy and pharmacokinetics of interferon alfa-2B and ribavirin in children with chronic hepatitis C.
    Bunn, S
    Kelly, D
    Murray, KF
    Shelton, M
    Olson, A
    Mieli-Vergani, G
    Zambas, D
    Gupta, SK
    Glue, P
    HEPATOLOGY, 2000, 32 (04) : 350A - 350A
  • [26] Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C
    Jen, JF
    Glue, P
    Ezzet, F
    Chung, C
    Gupta, SK
    Jacobs, S
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) : 407 - 421
  • [27] The cost-effectiveness of peginterferon alfa-2b (12KD) plus ribavirin vs. interferon alfa-2b plus ribavirin for chronic hepatitis C (CHC) in a developing country - Brazil
    Fonseca, MC
    Araujo, GTB
    VALUE IN HEALTH, 2005, 8 (06) : A119 - A120
  • [28] Induction of Autoimmune Hepatitis by Pegylated Interferon Alfa-2b in Chronic Hepatitis C
    Loerke, Julia
    Erhardt, Andreas
    Haeussinger, Dieter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) : A20 - A20
  • [29] Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents
    Al Ali, Jaber
    Owayed, Salem
    Al-Qabandi, Wafa'a
    Husain, Khaled
    Hasan, Fuad
    ANNALS OF HEPATOLOGY, 2010, 9 (02) : 156 - 160
  • [30] Cost-effectiveness of interferon alfa-2b combined with ribavirin as initial treatment of chronic hepatitis C in the German health care system.
    Siebert, U
    Sroczynski, G
    Wasem, J
    Ravens-Sieberer, U
    Greiner, W
    Bellach, BM
    Aidelsburger, P
    Corzillius, M
    Bullinger, M
    von der Schulenburg, JMG
    Wong, JB
    Rossol, S
    HEPATOLOGY, 2001, 34 (04) : 686A - 686A
12345